Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $5.680 million versus the consensus estimate of $6.17 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.